(firstQuint)Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea.

 To determine the efficacy of AzA foam, 15% compared to vehicle topically applied twice daily in papulopustular rosacea evaluated by therapeutic success rate according to Investigators Global Assessment (IGA) and change in inflammatory lesion count from baseline to end of treatment.

 Evaluation of all adverse events will be covered in Adverse Events section.

.

 Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea@highlight

The purpose of this study is to assess the safety and efficacy of azelaic acid (AzA) foam, 15% topically applied twice daily for 12 weeks in subjects with papulopustular rosacea compared to its vehicle.

